-

Agilent Again Named to Newsweek’s List of America’s Most Responsible Companies

Moves up 28 places from 2022

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the company is ranked 101 in Newsweek’s 2023 list of America’s Most Responsible Companies, up 28 places from 2022. It marks Agilent’s fourth consecutive year on the prestigious list, which includes the best-performing companies based on their environmental, social, and governance (ESG) activities. Agilent also ranked 10 among healthcare and life science companies, up from number 16.

To formulate the rankings, Newsweek and business intelligence firm Statista, Inc. reviewed corporate social responsibility and financial reports, analyzed quantitative data, and surveyed 13,000 U.S. residents on perceptions of ESG practices. They examined metrics on waste, emissions, energy use, water use, diversity and engagement, philanthropic giving, disclosure and transparency, and economic performance, among others.

“Agilent’s mission is to advance the quality of life,” said Agilent President and CEO Mike McMullen. “Receiving this recognition is gratifying because being a responsible corporate citizen is central to who we are. Focusing on corporate responsibility is woven into the fabric of our business and is part of what we strive to do every day.”

Agilent has reported on its environmental and community impact activities for over 20 years. Agilent further accelerated its environmental commitment in 2021 by adopting science-based targets for reducing emissions by 2030 and achieving net-zero emissions by 2050.

The company’s most recent ESG report showed progress during fiscal year 2021 on a number of critical metrics, including reducing carbon emissions intensity per square foot by 34 percent since 2014, increasing the share of women leaders reporting to the CEO by 30 percent, and achieving industry leading employee engagement levels.

The company released its first Task Force on Climate Related Financial Disclosures (TCFD) report in 2022 and reported on its plan to increase the share of women of color in leadership positions.

Since the release of its 2021 ESG report, Agilent has continued to progress in other areas, including work to advance diversity in STEM education through a $1 million donation to Delaware State University, a historically Black university; earning Great Place to Work certification in over 20 countries; and joining the How2Recycle program.

The Newsweek ranking adds to other recent recognition of Agilent, including Fortune’s Top Workplaces in Health Care, Top Project award from Environment +Energy Leader for instrument recycling and refurbishment, Forbes Top Female-Friendly Companies, and Investor’s Business Daily Best ESG Companies.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter and Facebook.

Contacts

MEDIA CONTACT:
Sarah Litton
+1 669 255 7696
sarah.litton@agilent.com

Agilent Technologies Inc. Logo
Agilent Technologies Inc. Logo

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Summary
Agilent announces the company is ranked 101 in Newsweek’s list of America’s Most Responsible Companies of 2023, up 28 places from 2022.
Release Versions

Contacts

MEDIA CONTACT:
Sarah Litton
+1 669 255 7696
sarah.litton@agilent.com

Social Media Profiles
More News From Agilent Technologies Inc.

Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has received European Union (EU) certification for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic indicated to aid in identifying patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma, whose tumors express PD-L1 and who may be eligible for treatment with KEYTRUDA® (pembrolizumab), Merck’s (known as MSD outside the United States and Canada) anti-PD-1 therapy. PD...

Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the PD‑L1 IHC 28‑8 pharmDx assay as a companion diagnostic to identify patients with esophageal squamous cell carcinoma (ESCC), gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG® (nivolumab and hyaluronidase‑nvhy), Bristol Myers Squibb’...

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.The new SEC and PLRP-S columns support critical analytical workflows across a range of biotherapeutic modalities, including peptides, proteins, oligonucleotides...
Back to Newsroom